Back

External validation study of the 2014 European Society of Cardiology Guidelines in relation to 2020 ACC/AHA guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy

3 April 2022 (08:20 - 20:00)
Organised by:
Congress Presentation Part of: ePosters Day 1 Congenital Heart Disease and Paediatric Cardiology, Other EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

128 More presentations in this session

Presentation thumbnail
Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation
Doctor I. Doundoulakis (Brussels, BE)
Abstract Slides
Presentation thumbnail
The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V
Doctor V. Weberndoerfer (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures
Mr T. Kueffer (Bern, CH)
Abstract Slides
Presentation thumbnail
Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort
Doctor C. Witt (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 1

The Event

Event poster

EHRA 2022

3 April 2022 08:20 CET
You may be interested in
thumbnail
Congress Presentation
Sudden cardiac death risk stratification in hypertrophic cardiomyopathy: discrepancies persist among guidelines
27 August 2021
thumbnail
Congress Presentation
Comparison of the 2016 and 2021 European Society of Cardiology and the 2019 American College of Cardiology/American Heart Association guidelines for primary cardiovascular prevention
28 August 2022
thumbnail
Congress Presentation
External validation and extension of the HCM-AF score for the prediction of atrial fibrillation in hypertrophic cardiomyopathy patients.
22 May 2023
thumbnail
Congress Session
Novel risk predictors in hypertrophic cardiomyopathy
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources